Back to MDGL
Cambridge Investment Research Advisors, Inc. → MDGL
Cambridge Investment Research Advisors, Inc. MDGL Position History
Madrigal Pharmaceuticals, Inc. • Healthcare
Quarters held
6
Latest value
$795K
Q3 2026
Peak value
$859K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $583K |
| Q4 2025 | $698K |
| Q1 2026 | $811K |
| Q2 2026 | $859K |
| Q2 2026 | $859K |
| Q3 2026 | $795K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $795K | 1.6K | — | — |
| Q2 2026 | $859K | 1.6K | — | — |
| Q2 2026 | $859K | 1.6K | — | — |
| Q1 2026 | $811K | 1.6K | — | — |
| Q4 2025 | $698K | 1.2K | — | — |
| Q3 2025 | $583K | 1.3K | — | — |
Other funds holding MDGL
$728.8M
$719.5M
$319.1M
$283M
$283M
$237.6M
$212.9M
$212.9M